| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0197-4580(01)00348-7 |
| P698 | PubMed publication ID | 12009497 |
| P2093 | author name string | Andreas Papassotiropoulos | |
| Christoph Hock | |||
| P2860 | cites work | Biomarkers of Alzheimer disease | Q30572676 |
| Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease | Q43708035 | ||
| Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils | Q43718666 | ||
| High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype. | Q45192211 | ||
| Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF. | Q48208608 | ||
| A new rating scale for Alzheimer's disease. | Q53197509 | ||
| CSF beta-amyloid, cognition, and APOE genotype in Alzheimer's disease. | Q53226428 | ||
| Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease. | Q53238052 | ||
| Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice | Q73632001 | ||
| P433 | issue | 4 | |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 513-514 | |
| P577 | publication date | 2002-07-01 | |
| P1433 | published in | Neurobiology of Aging | Q7002141 |
| P1476 | title | Biochemical markers of Alzheimer's disease: wish and reality | |
| P478 | volume | 23 |
| Q35125093 | Aspartic proteases involved in Alzheimer's disease |
| Q78344719 | Current awareness in geriatric psychiatry |
| Q47713062 | Frameshifted beta-amyloid precursor protein (APP+1) is a secretory protein, and the level of APP+1 in cerebrospinal fluid is linked to Alzheimer pathology |
| Q34831241 | Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses |
Search more.